Immunotherapy: Shifting the Balance of Cell-Mediated Immunity and Suppression in Human Prostate Cancer

Active immunotherapy is dependent on the ability of the immune system to recognize and respond to tumors. Despite overwhelming evidence to support a cell-mediated immune response to prostate cancer, it is insufficient to eradicate the disease. This is likely due to a high level of suppression at the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tucker, Jo A., Jochems, Caroline, Gulley, James L., Schlom, Jeffrey, Tsang, Kwong Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712722/
https://www.ncbi.nlm.nih.gov/pubmed/24213509
http://dx.doi.org/10.3390/cancers4041333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712722/
https://www.ncbi.nlm.nih.gov/pubmed/24213509
http://dx.doi.org/10.3390/cancers4041333

Ejemplares similares